Introduction
============

The peripherin/RDS gene encodes a glycoprotein which is confined to the outer segment disk of both rod and cone photoreceptor cells \[[@r1],[@r2]\]. The normal product of this gene, peripherin, interacts in vivo with rod outer segment membrane protein 1 (ROM1) in rods and plays an important structural role in photoreceptor outer segments \[[@r3]\]. Over 70 mutations in the peripherin/RDS gene have been reported in autosomal dominant retinitis pigmentosa (ADRP) and autosomal dominant macular dystrophy (adMD) \[[@r4]-[@r9]\], including a digenic trait with the ROM1 gene \[[@r10]\]. Phenotypic variation has been observed with different mutations in this gene, with an extreme case of variable phenotypes within a family having a single mutation showing retinitis pigmentosa (RP) and macular dystrophy (MD) \[[@r11],[@r12]\]. In our previous screening for mutations in the peripherin/RDS gene and in other RP and MD related genes in index cases of autosomal dominant retinopathies and simplex cases of RP, we found a lower contribution (1.3%) of mutations in peripherin/RDS to ADRP \[[@r13]\] in a Spanish population as compared to other screened populations. However, we found a relatively high association (23%) of mutations in this gene in families with autosomal dominant macular dystrophies. As reported in other populations, variability in macular dystrophy phenotype is also observed in this Spanish population. We report the different macular dystrophy phenotypes associated with mutations in the peripherin/RDS gene found in a Spanish population and compare these phenotypes with the associated mutations reported in other populations.

Methods
=======

A cohort of 61 unrelated patients with various types of autosomal dominant macular dystrophies, aged between 26 and 75 years, participated in this study. Patients were recruited from Fundación Jiménez Díaz (Madrid, Spain), Hospital de la Santa Creu i Sant Pau (Barcelona, Spain) and Hospital de Terrassa (Barcelona). A control group of 137 non-affected individuals was tested. Informed consent was obtained from all subjects who participated in the study and the research adhered to the tenets of the Declaration of Helsinki.

Ophthalmologic and electrophysiological studies
-----------------------------------------------

All individuals quoted above received a complete ophthalmic examination, which consisted of best corrected visual acuity with Snellen optotypes, color vision with Farnsworth 32 hue test, computerized perimetry (recorded on the Octopus 500) and biomicroscopy and fundus examination after pupillary dilation. Electroretinograms (ERG) and electrooculograms (EOG) were performed according to the standard testing protocols proposed by ISCEV \[[@r14]\].

Polymerase chain reaction
-------------------------

Genomic DNA was prepared from peripheral blood lymphocytes using QIAmp DNA Blood Mini Kit ([Qiagen](http://www1.qiagen.com), Valencia, CA;). Flanking intronic and coding regions of exons 1 and 2 of the peripherin/RDS gene were amplified using the primers shown in [Table 1](#t1){ref-type="table"}. One PCR primer in each pair included a 40-base GC-rich segment (\"GC-clamp\") attached to its 5\' end to facilitate detection of mutations by denaturing gradient gel electrophoresis (DGGE). PCR reactions were performed in a 50 ml volume of buffer (20 mM Tris-HCl, pH 8.55, 16 mM (NH)~2~SO~4~, 1.5 mM MgCl~2~ 150 mg/ml BSA, and 10% DMSO) containing 50-200 ng of human genomic DNA, 25 pmol of each primer, 10 nmol of each deoxyribonucleoside triphosphate, and 1.5 units of Taq polymerase (Ecotaq, Barcelona, Spain). Incubation was performed for 40 cycles consisting of 30 s at 94 °C, 30 s at 60 °C (for exons 1A and 1B), 63 °C (for exon 2) or 54 °C (for exon 3), and 30 s at 72 °C. This was followed by 5 min at 94 °C and 5 min at 72 °C. Electrophoresis of 8 ml of final PCR reaction volume was performed on 1.5% agarose gel to test the amplification reaction.

###### Primers and conditions used for mutation detection.

  ------------ ------------------------------ -------------------------------- ------------------------ -------------------
  **Primer**   **Sequence\* (5\'-3\')**       **Annealing temperature (°C)**   **Amplicon size (bp)**   **DGGE gradient**
  Exon 1A      F: (GC)-GGAAGCAACCCGGACTACAC   60                               379                      40-70%
               R: TAGCCAGGTACGGCTTCAGC                                                                  
  Exon 1B      F: (GC)-ATTGCATGGAAGCCCTG      60                               379                      40-70%
               R: TCTGACCCCAGGACTGGAAG                                                                  
  Exon 2       F: (GC)-AAGCCCATCTCCAGCTGT     63                               353                      45-75%
               R: CTTACCCTCTACCCCCAGCTG                                                                 
  Exon 3       F: AGATTGCCTCTAAATCTCCT        54                               294                      \-
               R: GGAGTGCACTATTTCTCAGT                                                                  
  ------------ ------------------------------ -------------------------------- ------------------------ -------------------

Within the table, (GC) represents: 5\'- CCG CCG CGC CCG CGC CCG GCC CGC CGC CCC CGC CCG-3\'. DGGE means denaturing gradient gel electrophoresis. In DGGE gradient column, 100% denaturant equals to 7M urea and 40% (v/v) formamide.

Mutation detection
------------------

PCR-amplified fragments containing the flanking intronic and coding sequences of exons 1 and 2 of the peripherin/RDS gene were analyzed. Exon 1 was divided into two PCR fragments, 1A and 1B. Screening for mutations was carried out by DGGE \[[@r15],[@r16]\]. Electrophoretic conditions (running temperature and denaturing gradient of formamide/urea concentration range for each different PCR product) are shown in [Table 1](#t1){ref-type="table"}. The PCR-amplified DNA fragment containing exon 3 of peripherin/RDS was sequenced directly because it is difficult to analyze by DGGE. When DGGE variants were observed, the corresponding PCR fragment was sequenced. For DNA sequencing, PCR products were purified using Qiaquick Gel Extraction Purification Kit (Qiagen). DNA sequencing was carried out with the same primers used for amplification with the OpenGene automated DNA sequencing system from Visible Genetics and Thermo Sequenase Cy5.5 Dye Terminator Cycle Sequencing Kit (Amersham Pharmacia Biotech, Barcelona, Spain). Prediction of the pathogenesis of the missense mutations was performed using [PolyPhen](http://genetics.bwh.harvard.edu/pph/) (Polymorphism phenotyping) program from the Harvard University.

Results
=======

Out of a total of 61 families studied, we found 13 different mutations in peripherin/RDS in 15 families with adMD ([Table 2](#t2){ref-type="table"}). These mutations were absent in 137 controls used in peripherin/RDS mutation screening. Co-segregation of the mutation was performed in each family and a complete penetrance was observed in all of them.

###### Mutations in the peripherin/RDS gene found in nish patients with autosomal dominant macular dystrophy.

  ---------- ----------------- -------------------- --------------------------- --------------- -------------------------
  **Exon**   **cDNA change**   **Protein change**   **PSIC score difference**   **Phenotype**   **Reference**
  1B         658 TAC\>CAC      Tyr141His            2.148                       AVDM            \[[@r27]\]
  1B         661 CGG\>TGG      Arg142 Trp           2.118                       CACD            \[[@r27],[@r28]\]
  1B         678 del T         Gly148AlafsX152      \-                          CACD            \[[@r29]\]
  1B         751 CGG\>TGG      Arg172Trp            2.606                       CACD            \[[@r4],[@r21]-[@r25]\]
  2          821 CGA\>CTA      Arg195Leu            2.745                       PMD             \[[@r30]\]
  2          846_862 del       Tyr204Pro fsX211     \-                          PMD             \[[@r29]\]
  2          860 GGC\>GAC      Gly208Asp            1.843                       PMD             \[[@r29],[@r31]\]
  2          875 TGC\>TTT      Cys213Phe            3.665                       AVMD            Present study
  2          878 TGC\>TAC      Cys214Tyr            3.665                       PMD             \[[@r27]\]
  2          895 CGG\>TGG      Arg220Trp            2.97                        BPD             \[[@r21]\]
  2          948_959 del       Asp237_Thr240del     \-                          BPD             Present study
  2          975-978 dupGGTG   Arg248Gly fsX301     \-                          PMD             Present study
  Intron 2   IVS2+2 T\>C       \-\-\--              \-                          PMD             Present study
  ---------- ----------------- -------------------- --------------------------- --------------- -------------------------

The following abbreviations were used: adult vitelliform macular dystrophy (AVMD); butterfly-shaped pattern dystrophy (BPD), central areolar choroidal dystrophy (CACD), and pattern macular dystrophy (PMD). Position-specific independent counts (PSIC) score calculates the difference between first and second amino acid variant.

Eight previously unreported families, are shown in [Figure 1](#f1){ref-type="fig"}. Two of these mutations, Arg142Trp and Arg172Trp, were detected in two unrelated Spanish families. Seven mutations found in the peripherin/RDS gene are missense mutations, and three, Tyr141His, Arg142Trp, and Cys213Phe, have only been reported in a Spanish population, while the Arg195Leu, Cys214Tyr, and Arg220Trp mutations have also been found in other populations. Of the nonsense mutations found, two are deletions (678delT and 846_862del), and one is a 4 bp GGTG duplication. Additionally, IVS2+2T\>C, a mutation located in the intron 2 flanking splicing region, was found. To predict the possible impact of this mutation in splicing, we used [Splice](http://www.fruitfly.org/seq_tools/splice.html) site prediction by neural network. This program predicted a donor site in the exon/intron boundary (GT) of intron 2, with a score of 0.98. We used a cutoff 0.40 for donor or acceptor sites. When mutation IVS2+2T\>C occurs, no donor site is predicted in exon/intron boundary of intron 2, suggesting that this mutation probably abolishes the canonical splice site.

![Pedigrees of novel reported Spanish families with mutation in the peripherin/RDS gene. Solid, open, and scored symbols indicate affected, unaffected and deceased individuals, respectively; arrows indicate probands. Bottom numbered symbols in pedigree correspond to individuals whose DNA has been analyzed by DGGE and sequencing- In chromatogram of direct genomic sequencing of mutation, arrows indicate position of mutation. AVMD indicates adult viteliform macular dystrophy; BPD indicates butterfly-shaped pattern dystrophy; CACD indicates central areolar choroidal dystrophy; PMD indicates pattern macular dystrophy.](mv-v13-1031-f1){#f1}

The nonsense and splicing mutations identified are only reported in a Spanish population. These nonsense mutations presumably generate truncated proteins.

Ophthalmic examination and clinical studies of patients were performed according to previously established protocols. Different phenotypes, including central areolar choroidal dystrophy (CACD), adult vitelliform macular dystrophy (AVMD), and pattern macular dystrophy (PMD; [Figure 2](#f2){ref-type="fig"}) were found for these peripherin/RDS mutations. [Table 3](#t3){ref-type="table"} summarizes the clinical features of the families.

![Funduscopic pictures of the different patterns observed in Spanish families with autosomal-dominant macular dystrophy families of a Spanish population. **A**: Central areolar choroidal dystrophy (CACD) caused by mutation Arg142Trp in index patient (male, 39 years old) of family adMD-25. **B**: Pattern macular dystrophy (PMD) present in index patient (male, 33 years old) of family adMD-48, carrier of mutation Arg195Leu. **C**: Adult vitelliform macular dystrophy caused by mutation Cys213Phe in patient II.4 (male, 34 years) of family adMD-136.](mv-v13-1031-f2){#f2}

###### Summary of clinical aspects in mutated families.

  -------------------------- ----------------------------------- ----------------------------------------- --------------------- --------------------------- -------------------------------------------------------------------------------- --------------------------------------------------------
  **Mutation (family)**      **Onsent of vision loss (years)**   **Age at visual acuity \<1/10 (years)**   **Central VF loss**   **Photo/Metam**             **Macula**                                                                       **ERG**
  Tyr141His (DM-24)          40                                  \-\--                                     \+                    +/-                         Yellowish lesions at macullae. Atrophy and destructuration of RPE. AVMD          decrease amplitude \"b\" wave in rods, mixed and cones
  Arg142Trp (DM-25)          35                                  50                                        \+                                                Subretinian yellowish spots at macullae. RPE destructuration and atrophy. CACD   
  Arg142Trp (DM-115)         37                                  55                                        \+                                                CACD                                                                             decrease \"b\" wave in cones
  Gly148Ala fsX152 (DM-3)    40-45                               50                                        \+                    -/-                         Subretinian yellowish round lesions. RPE destructuration and atrophy. CACD       decrease \"b\" wave in rods, mixed and cones
  Arg172Trp (DM-15b)         40                                  60                                        \+                    +/+                         Irregular pigmentation. Demarcated atrophy of central retina. CACD.              Normal
  Arg172Trp (DM-16b)         35-55                               60-75                                     \+                    +/+                         Demarcated atrophy of central retina. CACD.                                      Normal
  Arg195Leu (DM-48)          14                                  26                                        ++                                                Yellow deposits. Destructuration of RPE. PMD.                                    Not Performed
  Tyr204ProfsX211 (DM-2)     50-70                               55-75                                     +/-                   +/+                         Yellow deposits. Destructuration of RPE. PMD.                                    Not Performed
  Gly208Asp (B-263)          36                                                                            \+                    -/+                         RPE atrophy Flecks in macula. PMD.                                               Photopic: Normal; Scotopic: Normal
  Cys213Phe (DM-136)         34                                  34                                        \+                    \+                          AVMD                                                                             Normal RE decrease \"b\" wave in cones LE
  Cys214Tyr (DM-13)          35                                                                            \-                    -/+                         Starred aspect and destructuration of RPE. PMD.                                  Not Performed
  Arg220Trp (B-197)          45                                                                            \+                    Total central visual loss   BPD                                                                              Photopic: Normal; Scotopic: Normal
  Asp237_Thr240del (B-271)   43                                                                            \-                    +/+                         BPD                                                                              Photopic: Normal; Scotopic: Diminished
  Arg248GlyfsX301 (B-206)    36                                                                                                  -/+                         Macula RPE alteration. PMD.                                                      Photopic: Normal; Scotopic: Normal
  IVS2+2T\>C                 48 years                                                                      \+                    -/-                         Central RPE atrophy. PMD.                                                        
  -------------------------- ----------------------------------- ----------------------------------------- --------------------- --------------------------- -------------------------------------------------------------------------------- --------------------------------------------------------

AVMD indicates adult viteliform macular dystrophy; BPD indicates butterfly-shaped pattern dystrophy; CACD indicates central areolar choroidal dystrophy, ERG indicates electroretinogram, LE indicates left eye, Metam indicates metamorphosia, N.A indicates not available, Photo indicates photophobia, RE indicates right eye, V.F indicates visual field.

Discussion
==========

Peripherin/RDS is an integral membrane protein essential to outer segment disk morphogenesis of rod and cone photoreceptor outer segments in the retina \[[@r1]-[@r3],[@r17]-[@r19]\]. Mutations in the peripherin/RDS gene cause a large variety of autosomal dominant retinal degenerations, ranging from RP to MD \[[@r4]\].

In a Spanish population of nearly 200 index cases with ADRP, we detected a lower frequency (1.3%) of mutations in peripherin/RDS than in other reported populations \[[@r13]\]. However, we observed a relatively high frequency (23%) of mutations in peripherin/RDS among autosomal dominant Spanish families with central retinal dystrophies (adMD), slightly higher than that seen in other studies of adMD (18% of AVMD) \[[@r20]\], and 7.3% of adMD in a British population \[[@r21]\].

Specific mutations in the peripherin/RDS gene may lead to a wide inter- and intra-familial variability of phenotypes. Although phenotype-genotype correlations have been suggested depending on the location and type of mutations in peripherin/RDS, a general rule cannot yet be established. However, a common phenotype of adMD has been described for the most reported mutation, Arg172Trp, found in British, Swiss, Swedish, Japanese, and Spanish populations \[[@r21]-[@r25]\]. But for the Cys214Tyr mutation, an MD phenotype has been found in one of the Spanish families, while a mutation in the same codon but causing a different amino acid residue substitution, Cys214Ser, has been previously reported to be associated with an RP phenotype \[[@r26]\].

Most pathogenic mutations associated with human retinal dystrophies alter a conserved extracellular/intradiscal domain, EC2, in the protein. Studies carried out by Goldberg et al. \[[@r17]\] showed that changes within the EC2 domain may cause either gross protein misfolding as well as a reduction in protein sedimentation coefficient, while mutations outside the EC2 domain do not seem to affect the protein folding and tetrameric subunit assembly formed by peripherin/RDS and ROM1 protein. All mutations described here lie in EC2, or they produce a predictable truncated protein within this domain. This finding, together with the experimental results observed with peripherin/RDS mutants, suggest a pathogenic mechanism associated with misfolding or reduction of tetrameric subunit assembly in cones that leads to macular degeneration in the retina. Research carried out with animal models by Kedzierski et al \[[@r18]\] studying *rds* and *rom1* transgenic/knockout mice found that photoreceptor degeneration in peripherin/RDS-mediated RP appears to be caused by a simple deficiency of *rds* and *rom1*. Thus, below a critical threshold for the combined abundance of rds and rom1, the extent of outer segment (OS) disorganization results in clinically significant photoreceptor degeneration. In this case, a general haploinsufficiency mechanism could be hypothesized, that isspecially associated with mutations producing null alleles. However, in our studies, the severity and phenotype of the two frameshift changes reported (857del17bp, causing PMD, and 689delT, causing CACD) are not well correlated with the type of mutation and they produced different types of retinal affectation. Although a haploinsufficiency mechanism mediated by peripherin/RDS mutations could not be discarded, more plausible is a pathogenic mechanism that involves a negative dominant effect that could be modulated by other genetic elements that can contribute to the observed heterogeneity of retinal disease phenotypes.

The present study confirms that phenotype-genotype correlation is only feasible for a restricted number of peripherin/RDS mutations, including the most frequently observed Arg172Trp. More descriptions are needed to provide more clues to understanding the underlying mechanisms of photoreceptor degeneration as a consequence of peripherin/RDS mutations

In conclusion, we report four novel mutations and observed a relatively high incidence of mutations in the peripherin/RDS gene in a population of Spanish families with autosomal dominant macular dystrophies with variable phenotypes. However, a relatively homogeneous intra-familial expression of the disease was noted.

We thank patients and family members who took part in this study. We are grateful to Ian Johnstone for his help with the English language edition. This research was partially supported by grants from FIS (Spanish government and EU organization) 04/1620, 05/1788, and 05/087.

[^1]: The first two authors contributed equally to this publication.
